About Contipro
Contipro is a Healthcare company based in Pardubice (Czechia) founded in 1990. It operates as a manufacturer of hyaluronic acid-based products. Contipro offers products and services including Sodium Hyaluronate, Wound Healing Products, Hyaluronan Specialities, Veterinary Products, and Anti-Ageing Ingredients. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and API Production. Its legal entity is Contipro as. Its competitors include Bloomage Biotechnology, Fidia Farma, Lifecore, Qingdao Kangyuan Pharmaceutica and Minxiang Biomedical and 4 more.
Company details
Contipro was founded in 1990 in Pardubice, Czech Republic, where hyaluronic acid-based products are manufactured from cell walls of Streptococcus zooepidemicus bacteria. These materials are applied in tissue engineering, wound healing, nanotechnology, and drug delivery systems within the biotechnology sector. Final pharmaceutical products derived from various polysaccharides are also produced. A laboratory device for nanofiber production has been developed to support research operations.
- Latest Funding Round$243.04K (USD), Grant
Dec 2022
- InvestorsEuropean Union
& 1 more
Products & Services of Contipro
Contipro offers a comprehensive portfolio of products and services, including Sodium Hyaluronate, Wound Healing Products, Hyaluronan Specialities, Veterinary Products, and Anti-Ageing Ingredients.
Ultra-pure hyaluronic acid for pharmaceutical and medical applications.
Advanced products using hyaluronic acid for tissue repair and healing.
Derivatives of hyaluronic acid for scientific and innovative uses.
Pharmaceuticals and devices for veterinary tissue biology.
Hyaluronic acid and peptides for cosmetic anti-ageing formulations.
Joint support products like Geloren for human and animal use.
Devices for nanofiber production in research applications.
Apps and channels of Contipro
its YouTube channel Contipro has 144 subscribers and 1 videos.
Videos from Contipro
The most watched videos on Contipro's YouTube channel, Contipro (144 subscribers). Click a video to play it here.
More on Contipro.
Funding Insights of Contipro
- Total Rounds 5
- Last Round Grant — $243,036
- First Round $23,893
(Jun 2015)
- Investors Count 2
All 5 funding rounds of Contipro with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2022 | $243,036 | Grant | – | – | |
| Jan 2021 | $288,040 | Grant | – | – | |
| May 2019 | $263,067 | Grant | – | – | |
| Jan 2017 | $421,036 | Grant | – | – | |
| Jun 2015 | $23,893 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Contipro
Contipro has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Union and Portál veřejné správy.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A digital platform for public administration services in Czech Republic. | – | gov.cz | Czech Republic | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Contipro
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Contipro
5 people are tracked at Contipro (3 in leadership, 2 in team).
| Name | Role | Group |
|---|---|---|
Vladimir Velebny | CEO | Leadership |
Vlastimil Hrobar | Head of Pilot Plant Unit | Leadership |
Jakub Netušil | Head of Technical Development Department | Leadership |
Michal Moravec | IT System Engineer | Team |
Pavlík Jaroslav | Technical Manager | Team |
Complete people profiles for Contipro
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Contipro
3 dated milestones of Contipro across 32 years, from founding to its latest funding, stage changes and deals.
- Founded Contipro is founded.
- Funding First funding round of $24K.
- Funding Latest funding round, Grant, of $243K.
Competitors of Contipro
Contipro has 9 listed competitors in our database. They include Bloomage Biotechnology, Fidia Farma, Lifecore, Qingdao Kangyuan Pharmaceutica and Minxiang Biomedical, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bloomagebioactive.com | 1998 | Jinan, China | – | – | Manufacturer of hyaluronic acid & pharmaceutical products | |
| fidiapharma.com | 1946 | Abano Terme, Italy | – | – | Proprietary hyaluronic acid treatments and derivatives are developed. | |
| lifecore.com | 1965 | Chaska, United States | – | 459 | Hyaluronan-based products for biomedical applications are developed. | |
| kangyuan.com.cn | 2001 | Qingdao, China | – | – | Operates as a CDMO specializing in hyaluronidase manufacturing. | |
| mxpharm.com | 2005 | Tianjin, China | – | – | CDMO focused on manufacturer of API drugs | |
| altergon.it | 2000 | Avellino, Italy | – | – | Develops and manufactures pharmaceutical products and medical devices for clients. | |
| viablife.com | 2015 | Hangzhou, China | – | – | APIs are produced by Viablife as a CDMO in pharmaceuticals. | |
| ildonghyaltech.com | 2016 | Cheongju-si, South Korea | – | – | Delivers contract-based manufacturing services for hyaluronic acid products. | |
| junuvcp.com | 2015 | India | – | – | Exports active pharmaceutical ingredients and chemicals worldwide via online platform. |
Detailed competitors of Contipro
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Contipro
The website of Contipro (contipro.com) receives about 2.3K visits a month and ranks #4,348,267 among all websites worldwide, #5,317 in Biotechnology and Pharmaceuticals.
- Monthly visits2.3K
▼ 38.8% vs previous month
- Unique visitors1.3K
per month
- Global rank#4,348,267
among all websites
- Category rank#5,317
Health · Biotechnology and Pharmaceuticals
- Bounce rate35%
- Pages per visit2.4
- Average visit1 min 47 sec
- DevicesDesktop 37% · Mobile 63%
Websites whose visitors overlap most with Contipro. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| hyalogic.com | 100% | 10.2K | #2,379,801 | View details | |
primev.com | primev.com | 98% | – | – | – |
| mibellebiochemistry.com | 77% | – | #1,185,989 | View details | |
gqusa.com | gqusa.com | 77% | – | – | – |
| evonik.com | 36% | 257.1K | #185,770 | View details |
Top companies in Biopharma Outsourcing & Drug Delivery
10 companies that operate in the same segment as Contipro (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Contipro
Contipro was founded in 1990 and raised its 1st funding round 25 years after it was founded.
Contipro is headquartered in Pardubice, Czechia.
Contipro was founded in 1990 in Pardubice, Czech Republic, where hyaluronic acid-based products are manufactured from cell walls of Streptococcus zooepidemicus bacteria. These materials are applied in tissue engineering, wound healing, nanotechnology, and drug delivery systems within the biotechnology sector. Final pharmaceutical products derived from various polysaccharides are also produced. A laboratory device for nanofiber production has been developed to support research operations.
Contipro's top competitors include Lifecore, Bloomage Biotechnology and Fidia Farma.
Contipro offers Sodium Hyaluronate, Wound Healing Products, Hyaluronan Specialities, Veterinary Products, and 3 more products and services.
Contipro has 2 investors. Key investors include European Union, and Portál veřejné správy.
Contipro operates through Contipro As.